JP2005517669A - Ｓｓｒｉ全身送達方法 - Google Patents

Ｓｓｒｉ全身送達方法 Download PDF

Info

Publication number
JP2005517669A
JP2005517669A JP2003556003A JP2003556003A JP2005517669A JP 2005517669 A JP2005517669 A JP 2005517669A JP 2003556003 A JP2003556003 A JP 2003556003A JP 2003556003 A JP2003556003 A JP 2003556003A JP 2005517669 A JP2005517669 A JP 2005517669A
Authority
JP
Japan
Prior art keywords
ssri
fluoxetine
pharmaceutically acceptable
disorder
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003556003A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517669A5 (https=
Inventor
マハシャブドゥ，アニュ
フランシン ケイ，マーサ
グラザー，ブライアン
ツァン，ジュンシオン
Original Assignee
デュラメッド ファーマシューティカルズ，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デュラメッド ファーマシューティカルズ，インコーポレイティド filed Critical デュラメッド ファーマシューティカルズ，インコーポレイティド
Publication of JP2005517669A publication Critical patent/JP2005517669A/ja
Publication of JP2005517669A5 publication Critical patent/JP2005517669A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2003556003A 2001-12-21 2002-12-20 Ｓｓｒｉ全身送達方法 Pending JP2005517669A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34325401P 2001-12-21 2001-12-21
US10/095,558 US7005138B2 (en) 2001-12-21 2002-03-12 Method of systematically delivering SSRIs
PCT/US2002/040808 WO2003055424A1 (en) 2001-12-21 2002-12-20 METHOD OF SYSTEMICALLY DELIVERING SSRIs

Publications (2)

Publication Number Publication Date
JP2005517669A true JP2005517669A (ja) 2005-06-16
JP2005517669A5 JP2005517669A5 (https=) 2005-12-22

Family

ID=26790345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003556003A Pending JP2005517669A (ja) 2001-12-21 2002-12-20 Ｓｓｒｉ全身送達方法

Country Status (7)

Country Link
US (1) US7005138B2 (https=)
EP (1) EP1465563A4 (https=)
JP (1) JP2005517669A (https=)
AU (1) AU2002357352B2 (https=)
CA (1) CA2471039A1 (https=)
MX (1) MXPA04006198A (https=)
WO (1) WO2003055424A1 (https=)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007513939A (ja) * 2003-12-09 2007-05-31 トランスファーマ メディカル リミテッド ポリペプチドの持続性送達用経皮システム
JP2009543858A (ja) * 2006-07-17 2009-12-10 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 向精神性薬物またはｇａｂａアゴニストと有機酸とを含むコンジュゲート、ならびに疼痛および他のｃｎｓ障害を治療するためのそれらの使用
JP2010524615A (ja) * 2007-04-27 2010-07-22 バイエル シェーリング ファーマ オイ 移植可能な投与システムの膜殻
JP2013534923A (ja) * 2010-06-22 2013-09-09 テバ ウィメンズ ヘルス インコーポレイテッド 過活動膀胱に関連する状態を治療する方法
JP2013535992A (ja) * 2010-06-22 2013-09-19 テバ ウィメンズ ヘルス インコーポレイテッド 抗コリン作動剤を含む膣内用デバイスおよびそれを作る方法
US8722923B2 (en) 2008-02-11 2014-05-13 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
US8916610B2 (en) 2010-09-22 2014-12-23 Ramot At Tel-Aviv University Ltd. Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
JP2018509389A (ja) * 2015-01-30 2018-04-05 リ・ガリ・ベスローテン・フエンノートシャップＬｉ Ｇａｌｌｉ Ｂ．Ｖ． 膣用薬物送達デバイス

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043071A1 (en) * 2002-06-21 2004-03-04 Pauletti Giovanni M. Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
US20050101666A1 (en) * 2003-11-07 2005-05-12 H. Lundbeck A/S Method of treating premenstrual dysphoric disorder with escitalopram
DK1933810T3 (da) * 2005-08-11 2013-01-28 Childrens Medical Center Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
US20090209622A1 (en) * 2006-11-21 2009-08-20 Smoller Jordan W Diagnosis of anxiety disorders
WO2008112641A2 (en) * 2007-03-09 2008-09-18 New York University Methods and compositions for treating thalamocortical dysrhythmia
BRPI0813461A2 (pt) * 2007-06-29 2014-12-23 Carmanah Technologies Corp Sistema de iluminação de área inteligente
KR101538748B1 (ko) * 2007-12-11 2015-07-22 메사추세츠 인스티튜트 오브 테크놀로지 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
EA201170297A1 (ru) * 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
DK2445570T3 (da) 2009-06-26 2013-02-25 Taris Biomedical Inc Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8377929B2 (en) 2010-02-24 2013-02-19 Ramot At Tel-Aviv University Ltd. Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
JP2014503554A (ja) 2011-01-10 2014-02-13 タリス バイオメディカル，インコーポレイテッド 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
EP2670398B1 (en) 2011-02-04 2017-06-07 TARIS Biomedical LLC Implantable device for controlled release of low solubility drug
GB201115592D0 (en) * 2011-09-09 2011-10-26 Vivosens Medical Gmbh Flexible ring pessary
WO2014008118A2 (en) * 2012-07-02 2014-01-09 The General Hospital Corporation Method for concurrent treatment of pain and depression
USD703319S1 (en) * 2012-09-07 2014-04-22 Vivosensmedical Gmbh Ring pessary
KR102557326B1 (ko) 2013-03-15 2023-07-19 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치
KR102385603B1 (ko) 2013-08-19 2022-04-11 타리스 바이오메디컬 엘엘씨 다중 유닛 약물 전달 장치 및 방법
CN104546267B (zh) * 2015-01-13 2017-01-04 安徽农业大学 一种犬用宫外节育装置及其节育方法
WO2016172704A1 (en) 2015-04-23 2016-10-27 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
CA201547S (en) 2019-03-08 2022-01-28 Rite Hite Holding Corp Mounting device for fan and light

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0984855A (ja) * 1995-09-25 1997-03-31 Kyoto Yakuhin Kogyo Kk 直腸または膣への薬物投与用のエアゾール製剤
JPH09131404A (ja) * 1995-11-01 1997-05-20 Roussel Uclaf 腟内薬剤放出器具
JPH119699A (ja) * 1997-06-24 1999-01-19 Hoechst Marion Roussel 腟内薬物供給装置
WO2000010536A1 (en) * 1998-08-25 2000-03-02 Columbia Laboratories (Bermuda) Limited Extended release buccal bioadhesive tablet
WO2001012155A1 (en) * 1999-08-17 2001-02-22 Lipocine, Inc. Compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
WO2001080937A1 (en) * 2000-04-20 2001-11-01 Metris Therapeutics Limited Drug delivery device for insertion in the vagina, rectum or nasal cavity
JP2005503389A (ja) * 2001-08-31 2005-02-03 シエーリング オサケユイチア 薬物送達システム

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4442113A (en) * 1981-05-07 1984-04-10 A/S Ferrosan Long-term weight reduction of obese patients using femoxetine
AU3601897A (en) * 1996-07-15 1998-02-09 Alza Corporation Novel formulations for the administration of fluoxetine
JP2001502302A (ja) * 1996-09-19 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション 尿失禁を治療する方法
WO1999001121A1 (en) * 1997-07-01 1999-01-14 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
DE1073432T1 (de) * 1998-04-14 2002-02-07 The General Hospital Corp., Boston Verwendung von glycinrezeptoragonisten und glycinaufnahmeinhibitoren zur behandlung neuropsychiatrischer beschwerden
JP2002515435A (ja) * 1998-05-21 2002-05-28 イーライ・リリー・アンド・カンパニー 鬱病処置のための組合せ治療
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6239162B1 (en) 1999-05-17 2001-05-29 St. Elizabeth's Medical Center Method for treating depression
CA2371836C (en) * 1999-05-27 2006-01-31 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US20020192302A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of antidepressant drugs using basic enhancers
NZ591627A (en) * 2001-12-05 2012-09-28 Teva Womens Health Inc Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0984855A (ja) * 1995-09-25 1997-03-31 Kyoto Yakuhin Kogyo Kk 直腸または膣への薬物投与用のエアゾール製剤
JPH09131404A (ja) * 1995-11-01 1997-05-20 Roussel Uclaf 腟内薬剤放出器具
JPH119699A (ja) * 1997-06-24 1999-01-19 Hoechst Marion Roussel 腟内薬物供給装置
WO2000010536A1 (en) * 1998-08-25 2000-03-02 Columbia Laboratories (Bermuda) Limited Extended release buccal bioadhesive tablet
WO2001012155A1 (en) * 1999-08-17 2001-02-22 Lipocine, Inc. Compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
WO2001080937A1 (en) * 2000-04-20 2001-11-01 Metris Therapeutics Limited Drug delivery device for insertion in the vagina, rectum or nasal cavity
JP2005503389A (ja) * 2001-08-31 2005-02-03 シエーリング オサケユイチア 薬物送達システム

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007513939A (ja) * 2003-12-09 2007-05-31 トランスファーマ メディカル リミテッド ポリペプチドの持続性送達用経皮システム
JP2009543858A (ja) * 2006-07-17 2009-12-10 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 向精神性薬物またはｇａｂａアゴニストと有機酸とを含むコンジュゲート、ならびに疼痛および他のｃｎｓ障害を治療するためのそれらの使用
JP2010524615A (ja) * 2007-04-27 2010-07-22 バイエル シェーリング ファーマ オイ 移植可能な投与システムの膜殻
KR101461192B1 (ko) 2007-04-27 2014-11-13 바이엘 오와이 삽입형 투약 시스템의 막 외피
US8722923B2 (en) 2008-02-11 2014-05-13 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
JP2013534923A (ja) * 2010-06-22 2013-09-09 テバ ウィメンズ ヘルス インコーポレイテッド 過活動膀胱に関連する状態を治療する方法
JP2013535992A (ja) * 2010-06-22 2013-09-19 テバ ウィメンズ ヘルス インコーポレイテッド 抗コリン作動剤を含む膣内用デバイスおよびそれを作る方法
US8916610B2 (en) 2010-09-22 2014-12-23 Ramot At Tel-Aviv University Ltd. Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
JP2018509389A (ja) * 2015-01-30 2018-04-05 リ・ガリ・ベスローテン・フエンノートシャップＬｉ Ｇａｌｌｉ Ｂ．Ｖ． 膣用薬物送達デバイス

Also Published As

Publication number Publication date
EP1465563A1 (en) 2004-10-13
CA2471039A1 (en) 2003-07-10
US7005138B2 (en) 2006-02-28
AU2002357352A1 (en) 2003-07-15
US20030133977A1 (en) 2003-07-17
AU2002357352B2 (en) 2007-09-06
EP1465563A4 (en) 2010-06-30
MXPA04006198A (es) 2005-04-19
WO2003055424A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
JP2005517669A (ja) Ｓｓｒｉ全身送達方法
JP5986149B2 (ja) 女性の尿失禁を治療するための用具および方法
CN101080205B (zh) 含孕酮受体调节剂的缓释组合物
ES2239057T3 (es) Agentes de liberacion de hidroxido utilizados como potenciadores de la permeacion cutanea.
US20020161352A1 (en) Vaginal ring preparation and application
EP1671628B1 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
JPH11501629A (ja) ニトログリセリン含有の水性局所用クリーム；その製造方法及び使用
TW200831107A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Cicinelli Intravaginal oestrogen and progestin administration: advantages and disadvantages
AU2001245901A1 (en) Device and method for treating urinary incontinence in females
CA2383027C (en) Apparatus and method for anesthetizing the cervical region of a female
US20050197651A1 (en) Vaginal ring preparation and its application
Malcolm The intravaginal ring
RU2004122639A (ru) Способ получения 1r,2s-метоксамина, его терапевтическое применение (варианты) и фармацевтическая композиция
US10172869B2 (en) Progesterone receptor modulators for use in the therapy of uterine fibroids
EP2749286A1 (en) Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process
Woolfson Intravaginal drug delivery technologies
Acartürk et al. In‐vitro and in‐vivo evaluation of a matrix‐controlled bromocriptine mesilate‐releasing vaginal ring
KR20020071407A (ko) 신규한 직장투여용 액상좌제 조성물
KR20060123329A (ko) 월경 곤란증의 예방 및/또는 치료제
CN101693026A (zh) 单硝酸异山梨酯的新用途
HK1110789A (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090120

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090417

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090424

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090721

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100720

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101221